top of page

BackTable / Urology / Contributor

Dr. Aditya Bagrodia on the BackTable Urology Podcast

Dr. Aditya Bagrodia

Genioturinary Oncologist

Dr. Aditya Bagrodia is an associate professor of urology and genitourinary oncology team leader at UC San Diego Health in California and adjunct professor of urology at UT Southwestern.

Listen to Dr. Aditya Bagrodia on the BackTable Urology Podcast

The BackTable Podcast is a knowledge resource by physicians for physicians. Learn from the experiences and expertise of Dr. Aditya Bagrodia and get practical advice on how to build your practice by listening to the BackTable Urology Podcast.

Ep 82 Advocacy Basics for the Urologist: From Your Clinic to Capitol Hill with Dr. Ruchika Talwar
00:00 / 01:04

Earn CME

Reflect on how this Podcast applies to your day-to-day and earn free AMA PRA Category 1 CMEs. Follow the button below to claim your credits on CMEfy.

BackTable CMEfy button

Stay Up To Date

Follow:

Subscribe:

Sign Up:

About Dr. Aditya Bagrodia

Aditya Bagrodia, M.D., is an associate professor of urology and genitourinary oncology team leader at UC San Diego Health in California and adjunct professor of urology at UT Southwestern.

Dr. Bagrodia holds a bachelor of science degree from Rhodes College. While earning a medical degree with highest honors at the University of Tennessee Health Sciences Center, he was awarded a Doris Duke Clinical Research Fellowship at UT Southwestern Medical Center.

After completing his residency in urology at UT Southwestern, he received advanced training in urologic oncology through a fellowship at Memorial Sloan Kettering Cancer Center, where he was awarded a Urology Care Foundation Research Scholars Grant by the American Urological Association.

Dr. Bagrodia’s clinical practice focuses on treating all urologic malignancies, including adrenal, upper tract, renal, bladder, prostate, penile, and testicular cancers. He has expertise in complex multidisciplinary management and minimally invasive approaches to urologic surgery.

Dr. Bagrodia has conducted extensive research in urologic oncology, primarily in biomarker profiles and molecular signatures of urologic tumors as predictors of clinical outcomes. He is funded through competitive grants from the Cancer Prevention and Research Institute of Texas (CPRIT), intramural research grants, and the National Institutes of Health.

Both his clinical practice and research centers on patients with germ cell tumors (most commonly testicular cancer). His laboratory focuses on sequencing efforts to understand tumor evolution and heterogeneity in germ cell tumors and identifying novel biomarkers to recognize occult metastatic disease. The Bagrodia lab also conducts experiments in cell lines, zebrafish germ cell tumor models, and mice to understand the biologic implications of genetic alterations that are seen exclusively among patients with cisplatin-resistance disease. He is actively working on molecular biomarkers to identify minimal residual disease burden. On the clinical side, Dr. Bagrodia is actively involved in understanding and overcoming unique socioepidemiologic considerations that adversely impact oncologic outcomes in patients with germ cell tumors. He is also the principal investigator for several germ cell tumor-directed clinical trials at UT Southwestern (including NCT03426865 and NCT02537548).

Dr. Bagrodia is the principal author or co-author of more than 100 articles in peer-reviewed publications such as Journal of Clinical Oncology, Nature Genetics, European Urology, Journal of Urology, Urologic Oncology, and Urology. He is also a reviewer for many of these publications, as well as for the British Journal of Urology, Journal of Clinical Pathology, and Annals of Surgical Oncology.

Learn more by visiting Dr. Aditya Bagrodia's practice:

Podcasts Featuring Dr. Aditya Bagrodia

Episode #82

BackTable Podcast Play Button

In this episode of BackTable Urology, Dr. Aditya Bagrodia and Dr. Ruchika Talwar, a urologic oncology fellow at Vanderbilt University Medical Center, discuss her personal journey to becoming an advocate and how other urologists can get involved in policy making.

Episode #81

BackTable Podcast Play Button

In this episode of BackTable Urology, Dr. Aditya Bagrodia, Dr. Ari Hakimi (Memorial Sloan Kettering Cancer Center), and Dr. Nirmish Singla (Johns Hopkins University), discuss the value and indications for germline testing in renal cell carcinoma (RCC).

Episode #80

BackTable Podcast Play Button

In this episode of BackTable Urology, Dr. Aditya Bagrodia, Dr. Kara Watts (Montefiore Medical Center), Dr. Minhaj Siddiqui (University of Maryland), and Dr. Arvin George (University of Michigan) discuss active surveillance for prostate cancer.

Episode #79

BackTable Podcast Play Button

In this episode of BackTable Urology, Dr. Aditya Bagrodia interviews Dr. Todd Morgan, chief of urologic oncology at the University of Michigan, about benefits and indications for germline testing in prostate cancer patients.

Episode #78

BackTable Podcast Play Button

In this episode of BackTable Urology, Dr. Aditya Bagrodia interviews Dr. David Penson, professor and chair of urologic oncology at Vanderbilt University, about the indications and benefits of surgery for high risk prostate cancer.

Episode #76

BackTable Podcast Play Button

In this episode of BackTable Urology, Dr. Aditya Bagrodia interviews Marc McGuire and Patrick Scheffler about their personal experiences with prostate cancer, from diagnosis to remission.

Episode #70

BackTable Podcast Play Button

In this episode of BackTable Urology, Dr. Bagrodia discusses cultivating a healthy culture inside and outside of the operating room with Dr. Chris Kane, Dean of Clinical Affairs at UCSD and CEO of the UCSD Physician Group.

Episode #68

BackTable Podcast Play Button

In this episode of BackTable Urology, Dr. Bagrodia and Dr. Jay Raman, the chair of urology at Penn State Health, discuss advancements and future directions of medical education for trainees.

Episode #67

BackTable Podcast Play Button

In this episode of BackTable Urology, Dr. Bagrodia and Dr. Jay Simhan, director of reconstructive urology at Fox Chase Cancer Center, discuss how to demonstrate value at a private or academic physician job.

Episode #64

BackTable Podcast Play Button

In this episode of BackTable Urology, Dr. Aditya Bagrodia speaks with two fellow urologic oncologists, Dr. Timothy Clinton (Brigham and Women’s Hospital) and Dr. Eugene Pietzak (Memorial Sloan Kettering), about the management of BCG-refractory non muscle-invasive bladder cancer.

Episode #62

BackTable Podcast Play Button

In this episode, Dr. Aditya Bagrodia speaks with Dr. Manoj Monga, chair of the urology department at UC San Diego, about his unique journey to becoming a urologist as well as extra-academic passions that have led him to understand the importance of advocacy.

Episode #60

BackTable Podcast Play Button

In this episode, Dr. Aditya Bagrodia interviews pelvic floor therapist Vanita Gaglani from Vanita’s Rehab about the role of pelvic floor physical therapy for early continence recovery after prostatectomy.

Episode #59

BackTable Podcast Play Button

In this episode of BackTable Urology, Dr. Aditya Bagrodia discusses benefits and advice for effective mentorship with Dr. Andrew Winer, Chief of Urology at Kings County Hospital Center and assistant professor at SUNY Downstate.

Episode #58

BackTable Podcast Play Button

In this episode of BackTable Urology, Dr. Aditya Bagrodia discusses retroperitoneal lymph node dissection (RPLND) for early stage testicular cancer with Dr. Clint Cary and Dr. Timothy Masterson from Indiana University School of Medicine.

Episode #57

BackTable Podcast Play Button

In this episode of BackTable Urology, Dr. Aditya Bagrodia speaks with urologist Dr. Anne Schuckman from the University of Southern California about advantages and advice for blue light cystoscopy, a procedure performed to identify bladder tumors during transurethral resection of bladder tumor (TURBT).

Episode #56

BackTable Podcast Play Button

In this episode of BackTable Urology, Dr. Aditya Bagrodia speaks with urologist Dr. Karim Bensalah from the Universitaire de Rennes and medical oncologist Dr. Rana McKay from UC San Diego about adjuvant therapy for advanced kidney cancer.

Episode #54

BackTable Podcast Play Button

In this episode of BackTable Urology, Dr. Aditya Bagrodia discusses methods and benefits of smoking cessation in urologic oncology patients with Dr. Christian Fankhauser from Luzerner Kantonsspital and Dr. Richard Matulewicz from Memorial Sloan Kettering.

Episode #53

BackTable Podcast Play Button

In this episode of BackTable Urology, Dr. Aditya Bagrodia discusses radiation therapy for favorable intermediate-risk prostate cancer with radiation oncologist Dr. Amar Kishan, Chief of the Genitourinary Oncology Service for the Department of Radiation Oncology at UCLA.

Episode #51

BackTable Podcast Play Button

In this episode of BackTable Urology, Dr. Bagrodia discusses erectile dysfunction (ED) in the setting of post-prostate cancer treatment with Dr. Mike Hsieh and Dr. Darshan Patel, two urologists from the comprehensive men’s health clinic at UC San Diego Health.

Episode #49

BackTable Podcast Play Button

In this episode of BackTable Urology, Dr. Bagrodia interviews Dr. Alexander Kutikov, chief of urology and urologic oncology at Fox Chase Cancer Center, about diagnosis, lab and imaging workup, and surgical management of adrenal masses.

Episode #46

BackTable Podcast Play Button

In this episode of BackTable Urology, Dr. Aditya Bagrodia interviews Dr. Sam Chang, chief of urologic oncology at Vanderbilt University, about surgical tips and tricks for intermediate and high risk bladder cancer.

Episode #44

BackTable Podcast Play Button

In this episode of BackTable Urology, Dr. Aditya Bagrodia discusses tips and tricks for radical and partial prostatectomies with Dr. Rafael Coelho, Chief of Urology Oncology at the University of Sao Paulo School of Medicine.

Episode #43

BackTable Podcast Play Button

Dr. Aditya Bagrodia talks with Dr. Lee Zhao, director of the Male Reconstructive Surgery program at NYU Urology, about indications, surgical techniques, and post-operative management for patients requiring upper tract ureteral reconstruction.

Episode #42

BackTable Podcast Play Button

Dr. David Canes and host Dr. Aditya Bagrodia talk about attitudes, practices, and anecdotes to help resident and attending surgeons avoid complications.

Articles Featuring Dr. Aditya Bagrodia

Cystoscopic Image of Bladder cancer

BCG-unresponsive bladder cancer has distinct criteria for diagnosis and management. Official FDA diagnosis requires the development or recurrence of a high-grade bladder tumor after a patient has received adequate BCG therapy. Treatment duration varies based on whether an induction or maintenance course is indicated.

Histology of high grade bladder cancer

The management of high-grade BCG-unresponsive bladder cancer begins with the establishment of cytology and, based on the patient profile, is followed by either TURBT or total cystectomy. Alternative treatments are available, but ongoing research continues to explore other options.

Doctor holding cystoscope for TURBT procedure

Transurethral resections of bladder tumor (TURBT) is a common procedure that is used to treat bladder cancer. Urologic Oncologist Dr. Sam Chang shares his approach to successful bladder cancer resection with TURBT, covering his technique before, during, and after the TURBT procedure.

Testicular pain treatment consultation between physician and patient

Upper tract urothelial carcinoma is a rare entity with a lack of prospective data to guide clinical decisions. Dr. Shariat, who led the charge on building multicenter data sets for the condition, joins Dr. Bagrodia to discuss surgical management.

Doctor demonstrating prostate anatomy for potential radiotherapy complications

Urologists commonly utilize radiotherapy in the treatment of prostate cancer, but like most treatment modalities, it is not without its complications. Learn more about specific complications and the role of patient-specific and prostate-specific factors in determining candidacy for treatment. 

Male patient undergoing external radiation therapy

Internal radiation therapy and external radiation therapy are often used by Urologists in the treatment of prostate cancer. Understanding the differences between the two forms of radiation is pertinent for deciding the patient's treatment plan.

A transgender individual receiving a pelvic exam to evaluate for bottom surgery.

Many transgender individuals undergo gender affirming pelvic surgery, or bottom surgery. Since many travel for these surgeries, the original surgeon may not be available if complications arise. This article discusses common bottom surgery complications and their management.

A transgender woman talks to her doctor about gender affirming surgery

Transgender and gender diverse patients often seek urological care when they are interested in gender affirming surgery. This article discusses terminology and gender affirming surgery options available to transgender patients.

Blue light cystoscopy screening for bladder cancer recurrence

Blue light cystoscopy is useful in managing bladder cancer, both for complete tumor resection in the OR and as routine surveillance office cystoscopy to monitor bladder cancer recurrence.

Man being treated with radiation for prostate cancer.

When deciding on prostate cancer surgery vs radiation, it is important to know all of the pros and cons. They can both be effective treatments for prostate cancer, but you should be informed of the risks based on your age. This article covers both prostate cancer treatments.

A doctor consulting a patient about prostate cancer.

This article discusses the criteria to start prostate cancer active surveillance, various modalities to monitor disease progression, and indications to initiate other treatment.

A backtable set up for a ureteroscopy

A ureteroscopy should be performed if a stone fails trial of passage. This article breaks down the peri-operative and post-op care, as well as technique for this procedure.

Patient with a secured nephrostomy tube from treatment of obstructive pyelonephritis

Obstructive pyelonephritis can present as an emergency, and must be correctly identified and treated. This article discusses the diagnosis and treatment of this condition, along with medical management of a trial of passage.

Renal cell carcinoma with tumor thrombus in the interior vena cava

Tumor thrombus formation is common in locally advanced kidney cancer, and can lead to bland thrombus, pulmonary emboli, and even Budd-Chiari syndrome. The risk of pulmonary emboli creates unique challenges during kidney cancer surgery.

Kidney cancer surgery, specifically, a nephrectomy

Kidney cancer surgery can be aggressive or conservative, depending on various factors. This article discusses when to perform a partial vs. radical nephrectomy, the indications for lymph node dissection, and the viability of a robotic approach.

PCNL nephrostomy tube placement for kidney stones

PCNL is a minimally invasive surgical procedure that is used to remove large or complex kidney stones. Urologist Dr. Margaret Pearle explains when nephrostomy tube placement is appropriate and how they can stabilize post-operative bleeding.

PCNL Surgery Procedure Steps & Techniques for kidney stones

PCNL surgery is a minimally invasive alternative to open kidney stone surgery to remove kidney stones. Urologist Dr. Margaret Pearle shares her PCNL procedure steps and techniques and discusses the complications of PCNL surgery.

HoLEP procedure surgery

The HoLEP procedure, or holmium laser enucleation of the prostate, is a new BPH treatment that is widely used because of its minimal invasiveness and quicker recovery times. However, urologists should evaluate the HoLEP procedure pros and cons before they decide on the surgery.

urolift procedure device

The UroLift procedure is a minimally invasive, non-ablative BPH treatment that places permanent implants to pull the prostate lobes away from the urethra.

bipolar turp procedure device

The bipolar TURP procedure involves the use of a bipolar current to resect excess prostate tissue, alleviating symptoms in patients with benign prostate hyperplasia (BPH). Learn about Bipolar TURP surgery, advantages of bipolar TURP, and potential complications.

Urologist using the IPPS to evaluate patient with BPH

The International Prostate Symptom Score (IPSS) is a universal assessment endorsed by the AUA. The IPSS questionnaire consists of 7 questions and evaluates BPH patients from a score of 0 to 35.

5-alpha reductase inhibitors for BPH

5-alpha reductase inhibitors are a class of medications commonly used to treat BPH. They are most effective in BPH patients with large prostates. Learn more about using 5-alpha reductase inhibitors for BPH.

Blood test for testicular cancer markers.

Testicular cancer markers are the first step in working up a testicular mass, but are not elevated in all testis cancers. MicroRNA biomarkers are elevated in roughly 90% of testis cancers.

Young man consulting with his Urologist about testicular cancer and fertility after orchiectomy

The testes are responsible for sperm production, so many patients have concerns about testicular cancer and fertility preservation after radical orchiectomy. Learn about radical orchiectomy versus partial orchiectomy and the potential post-orchiectomy problems that could arise.

Get Connected

Thank you for listening! If you have a question for Dr. Aditya Bagrodia about a topic discussed on the BackTable Urology Podcast, you can get in touch with this form. Please note that our contributors are not able to respond to every inquiry.

Select which show(s) you would like to subscribe to:

Thanks! Message sent.

Disclaimer: The Materials available on BackTable.com are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.

backtable-earn-free-cme.jpg

Podcasts

Advocacy Basics for the Urologist: From Your Clinic to Capitol Hill with Dr. Ruchika Talwar on the BackTable Urology Podcast)
Germline Testing in Kidney Cancer with Dr. Ari Hakimi and Dr. Nirmish Singla on the BackTable Urology Podcast)
Active Surveillance for Prostate Cancer with Dr. Kara Watts, Dr. Minhaj Siddiqui, and Dr. Arvin George on the BackTable Urology Podcast)
Germline Testing in Prostate Cancer: Who, When, and How with Dr. Todd Morgan on the BackTable Urology Podcast)
Surgery for High-Risk Prostate Cancer with Dr. David Penson on the BackTable Urology Podcast)
New Technologies for Prostate Screening with Dr. Ali Kasraeian on the BackTable Urology Podcast)

Topics

Artifical Urinary Sphincter (AUS) Surgery Procedure Prep
Bipolar Transurethral Resection of the Prostate (TURP) Procedure Prep
Bladder Cancer Condition Overview
Cystoscopy Procedure Prep
Holmium Laser Enucleation of the Prostate (HoLEP) Procedure Prep
Pelvic Floor Therapy Procedure Prep

More Contributors

Dr. Sam Chang on the BackTable Urology Podcast

Dr. Sam Chang

Dr. Timothy Clinton on the BackTable Urology Podcast

Dr. Timothy Clinton

Dr. Siamak Daneshmand on the BackTable Urology Podcast

Dr. Siamak Daneshmand

Dr. Christian Fankhauser on the BackTable Urology Podcast

Dr. Christian Fankhauser

Dr. Richard Matulewicz on the BackTable Urology Podcast

Dr. Richard Matulewicz

Dr. Eugene Pietzak on the BackTable Urology Podcast

Dr. Eugene Pietzak

bottom of page